JP2001527581A - メントの経皮投与 - Google Patents

メントの経皮投与

Info

Publication number
JP2001527581A
JP2001527581A JP51815599A JP51815599A JP2001527581A JP 2001527581 A JP2001527581 A JP 2001527581A JP 51815599 A JP51815599 A JP 51815599A JP 51815599 A JP51815599 A JP 51815599A JP 2001527581 A JP2001527581 A JP 2001527581A
Authority
JP
Japan
Prior art keywords
transdermal
layer
androgen
dosage form
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51815599A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001527581A5 (cg-RX-API-DMAC10.html
Inventor
ムー―ヤン,アルフレッド,ジェイ.
ツォン,ユン―イェン
Original Assignee
ザ・ポピュレイション・カウンシル,インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・ポピュレイション・カウンシル,インコーポレイテッド filed Critical ザ・ポピュレイション・カウンシル,インコーポレイテッド
Publication of JP2001527581A publication Critical patent/JP2001527581A/ja
Publication of JP2001527581A5 publication Critical patent/JP2001527581A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
JP51815599A 1997-09-17 1998-09-17 メントの経皮投与 Pending JP2001527581A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5930197P 1997-09-17 1997-09-17
US09/154,287 US20020012694A1 (en) 1997-09-17 1998-09-16 Transdermal administration of ment
US60/059,301 1998-09-16
US09/154,287 1998-09-16
PCT/US1998/019399 WO1999013812A1 (en) 1997-09-17 1998-09-17 Transdermal administration of ment

Publications (2)

Publication Number Publication Date
JP2001527581A true JP2001527581A (ja) 2001-12-25
JP2001527581A5 JP2001527581A5 (cg-RX-API-DMAC10.html) 2005-09-08

Family

ID=26738606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51815599A Pending JP2001527581A (ja) 1997-09-17 1998-09-17 メントの経皮投与

Country Status (6)

Country Link
US (2) US20020012694A1 (cg-RX-API-DMAC10.html)
EP (1) EP0941039A4 (cg-RX-API-DMAC10.html)
JP (1) JP2001527581A (cg-RX-API-DMAC10.html)
BR (1) BR9806213A (cg-RX-API-DMAC10.html)
CA (1) CA2270177C (cg-RX-API-DMAC10.html)
WO (1) WO1999013812A1 (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
WO2003068314A1 (en) * 2002-02-15 2003-08-21 Pantarhei Bioscience B.V. Pulmonary administration of 6-alpha-alkylated testosterone derivatives for androgen replacement therapy
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
KR101041328B1 (ko) * 2002-07-24 2011-06-14 바이엘 쉐링 파마 악티엔게젤샤프트 7 알파-치환 11 알파-히드록시 스테로이드의 생산을위한 미생물학적 방법
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7879357B2 (en) * 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
US7056332B2 (en) * 2003-07-24 2006-06-06 Materials Evolution And Development Usa, Inc. Nucleic acid biomaterials and methods of formation and use
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
CN101489756B (zh) 2006-03-24 2013-08-07 奥克思利尤姆国际控股公司 热熔挤出层压材料的制备方法
CN101484142B (zh) 2006-03-24 2013-06-05 奥克思利尤姆国际控股公司 包含对碱性不稳定的药物的稳定组合物
US20070243714A1 (en) * 2006-04-18 2007-10-18 Applied Materials, Inc. Method of controlling silicon-containing polymer build up during etching by using a periodic cleaning step
CN102365308B (zh) 2009-01-12 2014-03-12 马萨诸塞大学卢维尔分校 聚异丁烯基聚氨酯
CN102573940B (zh) * 2009-08-21 2015-04-01 心脏起搏器公司 可交联聚异丁烯类聚合物及包含其的医疗装置
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
US9484123B2 (en) 2011-09-16 2016-11-01 Prc-Desoto International, Inc. Conductive sealant compositions
CN104520345B (zh) 2012-11-21 2017-10-03 马萨诸塞州大学 高强度聚氨异丁烯聚氨甲酸酯
WO2018165273A1 (en) 2017-03-07 2018-09-13 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
CN110997746B (zh) 2017-08-17 2021-12-28 心脏起搏器股份公司 用于增强的耐久性的光交联聚合物
WO2019143629A1 (en) 2018-01-17 2019-07-25 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
DE69202172T2 (de) * 1991-02-20 1995-11-30 Hitachi Automotive Eng Katalysatorsteuergerät.
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE59409873D1 (de) * 1993-04-20 2001-10-25 Hexal Ag Wirkstoffpflaster
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Also Published As

Publication number Publication date
CA2270177C (en) 2006-08-29
WO1999013812A1 (en) 1999-03-25
BR9806213A (pt) 2000-04-18
EP0941039A4 (en) 2006-06-21
US20020012694A1 (en) 2002-01-31
CA2270177A1 (en) 1999-03-25
EP0941039A1 (en) 1999-09-15
US20040126418A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU695170B2 (en) Transdermal delivery system with adhesive overlay and peel seal disc
CA2270177C (en) Transdermal administration of ment
US4687481A (en) Transdermal drug delivery system
JP2573638B2 (ja) 経皮的生殖能調節システムおよび方法
US4624665A (en) Method of transdermal drug delivery
US4927687A (en) Sustained release transdermal drug delivery composition
KR100392435B1 (ko) 성스테로이드를함유하는경피치료시스템
US4906169A (en) Transdermal estrogen/progestin dosage unit, system and process
FI107708B (fi) Menetelmä lääkkeenantolaitteessa käytettävän matriisin valmistamiseksi
EP0782861B1 (en) Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation
EP0448644A1 (en) METHOD, SYSTEM AND UNIT FOR TRANSDERMAL DOSING OF ESTROGEN / PROGESTINE.
IE873541L (en) Transdermal estrogen/progestin dosage unit
AU2007200426A1 (en) Transdermal delivery of lasofoxifene
JP7354242B2 (ja) イブプロフェンまたはその構造類似体を含む多層経皮薬物送達システム
JPH11209271A (ja) 経皮吸収製剤
CA3236288A1 (en) Occlusive plaster with flexible backing
WO2022212529A1 (en) Transdermal systems having low dose estrogen and methods of making and use
JP2507068B2 (ja) 経皮吸収製剤
CN101695483B (zh) 能独立控制的含有孕激素和雌激素的避孕透皮贴剂及制法
JPH11209270A (ja) 経皮吸収製剤
MXPA99004581A (en) Transdermal administration of ment
TWI298253B (en) Transdermal delivery of lasofoxifene

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041126

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20050909

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050926

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081022

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090106